Cash-Fat Vernalis to Boost Pipeline via Outside Route
LONDON — Bolstered by two fundraisings, Vernalis plc is on the hunt for a merger or acquisition that will bring an advanced and unpartnered clinical program into its pipeline. The company also is interested in in-licensing earlier-stage programs. (BioWorld International)
To continue reading subscribe now to BioWorld Asia (formerly International)
Learn More about BioWorld Asia (formerly International)
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.